Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04524208
Title A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (CABONEN)
Acronym CABONEN
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karsten Gavenis
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU | AUT


No variant requirements are available.